Black Rock Inc. Tonix Pharmaceuticals Holding Corp. Transaction History

Black Rock Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.46 - $1.3 $266 - $754	-580 Reduced 0.19%	301,858 $178,000
Q4 2022 Feb 13, 2023	SELL	$0.29 - $0.57 $1,993 - $3,917	-6,873 Reduced 2.22%	302,438 $117,000
Q3 2022 Nov 14, 2022	SELL	$0.53 - $1.9 $17,185 - $61,607	-32,425 Reduced 9.49%	309,311 $165,000
Q2 2022 Aug 12, 2022	BUY	$1.58 - $7.36 $539,942 - $2.52 Million	341,736 New	341,736 $541,000

Ticker TNXP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,752,700
Market Cap $7.25M
Description
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candid...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.